Figure 1
From: Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling
Kaplan–Meier analysis of age-specific penetrance of Parkinson disease (PD) among 224 obligate carriers of glucocerebrosidase (GBA) mutations (parents of patients with type 1 Gaucher disease). Penetrance by age 85 is estimated to be 10.9%.
